Biotech Co.'s Counterclaims Against Ex-Exec Trimmed
By Daniel Ducassi ( November 28, 2023, 10:30 PM EST) -- A California federal judge has tossed a Colorado biotechnology company's counterclaims alleging fraud and negligent misrepresentation by a co-founder and technology chief of another firm it acquired for $35 million in 2022, but allowed the biotech's bid for declaratory relief regarding the executive's exit from the company to move forward....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.